SARS-CoV-2 infection in children with chronic kidney disease
Sudarsan Krishnasamy(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Swarnim Swarnim(Maulana Azad Medical College), Rajni Gaind(Vardhman Mahavir Medical College & Safdarjung Hospital), Mukta Mantan(Maulana Azad Medical College), Shobha Sharma(Vardhman Mahavir Medical College & Safdarjung Hospital), Megha Brijwal(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha, Kanika Kapoor(Vardhman Mahavir Medical College & Safdarjung Hospital), Priyanka Khandelwal(Chacha Nehru Bal Chikitsalaya), Manish Kumar(Sterling Hospitals), Kirtisudha Mishra(Lady Hardinge Medical College)
Cited by 34
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203